CA
INSM icon

Crewe Advisors’s Insmed INSM Stock Holding History

Crewe Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-301
Closed -$5.13K – 945
2023
Q1 		$5.13K Hold
301
– – ﹤0.01% 631
2022
Q4 		$6.01K Hold
301
– – ﹤0.01% 644
2022
Q3 		$6K Hold
301
– – ﹤0.01% 802
2022
Q2 		$6K Buy
+301
New +$6.31K ﹤0.01% 721

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Crewe Advisors's INSM Position: Q2 2023 in Review

Crewe Advisors sold out of Insmed (INSM) in Q2 2023, closing a stake of 301 shares — an estimated $5.13K sold.

Crewe Advisors first reported a position in INSM in Q2 2022 and held it in 4 quarters. The position peaked at $6.01K in Q4 2022. 223 funds tracked by Wall St. Rank hold INSM as of Q2 2023.

  • Crewe Advisors reported no remaining Insmed position as of Q2 2023 after selling out during the quarter.
  • Crewe Advisors sold 301 Insmed shares in Q2 2023, an estimated $5.13K.
  • Crewe Advisors first reported a position in Insmed in Q2 2022 and held it in 4 quarters.
  • Crewe Advisors's Insmed position peaked at $6.01K in Q4 2022.
  • 223 funds tracked by Wall St. Rank held Insmed as of Q2 2023.

Based on Crewe Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.